2025 Mid-Year Portfolio Review

On January 4 2025, I published my 2024 Year End Portfolio Review. I never disclose details of what I hold in retirement accounts. I do, however, include these holdings in determining my exposure to various companies. My prior semi-annual reviews have, therefore, been incorrectly labelled as FFJ Portfolio reviews. The monthly recaps, however, only include [...]

FFJ Portfolio – June 2025

This FFJ Portfolio - June 2025 report is a high-level recap of my activity during the month. Looking at the Financial Industry Regulatory Authority, Inc. (FINRA) monthly margin statistics, we see a return in investors' willingness to borrow for investment purposes (Debit Balances in Customers' Securities Margin Accounts). Despite the return of irrational exuberance, I [...]

Rollins Avoids Tariff Headwinds

Rollins (ROL) may not appeal to some investors because the nature of its business is not 'sexy'. Sometimes, however, 'ho hum' businesses can offer investors the potential for very reasonable long-term total shareholder returns. Through its family of brands, ROL provides pest control, termite services and wildlife removal to residential and commercial customers. Looking at [...]

Copart’s Valuation Improves

Copart's valuation improves despite no fundamental change in the company's long term outlook. I have, therefore, acquired an additional 200 shares @ ~$48.12 in a 'Core' account in the FFJ Portfolio on June 18. This is a brief post because I covered CPRT as recently as May 28, 2025 where I disclose the purchase of [...]

Intuitive Surgical – Redefining The Future of Surgery with Innovation

Intuitive Surgical (ISRG) is redefining the future of surgery with innovation. Its da Vinci platform ranks as being one of the most disruptive technologies in medtech history thus leading to the company's remarkable success in rewarding long-term shareholders. I last reviewed ISRG in this January 25, 2025 post at which time shares were trading at [...]

Why I Added Howard Hughes Holdings (HHH) To The FFJ Portfolio

I have previously looked at Howard Hughes Holdings (HHH) but very quickly determined I wanted no exposure. I now have a different perspective because the historical HHH will not resemble HHH of the future. So what has changed? In this May 2025 interview, Bill Ackman (the founder and CEO of Pershing Square Capital Management) provides [...]

By |June 3rd, 2025|Equity Investing|Comments Off on Why I Added Howard Hughes Holdings (HHH) To The FFJ Portfolio

FFJ Portfolio – May 2025

This FFJ Portfolio - May 2025 report is a high-level recap of my activity during the month. Several buying opportunities presented themselves in April. May, however, was a very different story with the return of irrational exuberance. Looking at the Financial Industry Regulatory Authority, Inc. (FINRA) monthly margin statistics, I suspect some investors experienced a [...]

By |May 31st, 2025|FFJ Portfolio Holdings|Comments Off on FFJ Portfolio – May 2025

Agilent Remains Undervalued

I last reviewed Agilent (A) in this February 28, 2025 post at which time the most current financial information was for Q1 2025. With the recent release of Q2 and YTD2025 results and an update to the FY2025 outlook, I revisit this existing holding. Business Overview A has the following 3 reportable business segments: life [...]

By |May 30th, 2025|Equity Investing|Comments Off on Agilent Remains Undervalued
Go to Top